You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers
|
|---|---|
| Published in |
BMC Cancer, July 2013
|
| DOI | 10.1186/1471-2407-13-339 |
| Pubmed ID | |
| Authors |
Reka Pataky, Linlea Armstrong, Stephen Chia, Andrew J Coldman, Charmaine Kim-Sing, Barbara McGillivray, Jenna Scott, Christine M Wilson, Stuart Peacock |
| Abstract |
Women with mutations in BRCA1 or BRCA2 are at high risk of developing breast cancer and, in British Columbia, Canada, are offered screening with both magnetic resonance imaging (MRI) and mammography to facilitate early detection. MRI is more sensitive than mammography but is more costly and produces more false positive results. The purpose of this study was to calculate the cost-effectiveness of MRI screening for breast cancer in BRCA1/2 mutation carriers in a Canadian setting. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 25% |
| Ecuador | 1 | 25% |
| Unknown | 2 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 75% |
| Scientists | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 122 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Malaysia | 1 | <1% |
| Unknown | 120 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 22 | 18% |
| Student > Bachelor | 16 | 13% |
| Student > Master | 11 | 9% |
| Student > Postgraduate | 9 | 7% |
| Student > Doctoral Student | 8 | 7% |
| Other | 26 | 21% |
| Unknown | 30 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 44 | 36% |
| Nursing and Health Professions | 11 | 9% |
| Economics, Econometrics and Finance | 11 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 4% |
| Social Sciences | 4 | 3% |
| Other | 17 | 14% |
| Unknown | 30 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 July 2013.
All research outputs
#13,311,993
of 22,713,403 outputs
Outputs from BMC Cancer
#2,925
of 8,265 outputs
Outputs of similar age
#101,747
of 194,204 outputs
Outputs of similar age from BMC Cancer
#30
of 70 outputs
Altmetric has tracked 22,713,403 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,265 research outputs from this source. They receive a mean Attention Score of 4.3. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 194,204 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 70 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.